Ueda S - Search Results

1

Optical imaging for monitoring tumor oxygenation response after initiation of single-agent bevacizumab followed by cytotoxic chemotherapy in breast cancer patients.

Ueda S, Kuji I, Shigekawa T, Takeuchi H, Sano H, Hirokawa E, Shimada H, Suzuki H, Oda M, Osaki A, Saeki T. Ueda S, et al. PLoS One. 2014 Jun 6;9(6):e98715. doi: 10.1371/journal.pone.0098715. eCollection 2014. PLoS One. 2014. PMID: 24905225 Free PMC article.

2

Optical imaging of tumor vascularity associated with proliferation and glucose metabolism in early breast cancer: clinical application of total hemoglobin measurements in the breast.

Ueda S, Nakamiya N, Matsuura K, Shigekawa T, Sano H, Hirokawa E, Shimada H, Suzuki H, Oda M, Yamashita Y, Kishino O, Kuji I, Osaki A, Saeki T. Ueda S, et al. BMC Cancer. 2013 Oct 31;13:514. doi: 10.1186/1471-2407-13-514. BMC Cancer. 2013. PMID: 24176197 Free PMC article.

3

Clinicopathological and prognostic impact of imaging of breast cancer angiogenesis and hypoxia using diffuse optical spectroscopy.

Nakamiya N, Ueda S, Shigekawa T, Takeuchi H, Sano H, Hirokawa E, Shimada H, Suzuki H, Oda M, Osaki A, Saeki T. Nakamiya N, et al. Among authors: ueda s. Cancer Sci. 2014 Jul;105(7):833-9. doi: 10.1111/cas.12432. Epub 2014 Jun 27. Cancer Sci. 2014. PMID: 24766271 Free PMC article.

4

Near-infrared optical imaging of cancer vascular remodeling after antiangiogenic therapy.

Ueda S, Saeki T. Ueda S, et al. Breast Cancer. 2014 Nov;21(6):776-9. doi: 10.1007/s12282-014-0534-2. Epub 2014 May 4. Breast Cancer. 2014. PMID: 24795075

5

Neoadjuvant triweekly nanoparticle albumin-bound paclitaxel followed by epirubicin and cyclophosphamide for Stage II/III HER2-negative breast cancer: evaluation of efficacy and safety.

Shimada H, Ueda S, Saeki T, Shigekawa T, Takeuchi H, Hirokawa E, Sugitani I, Sugiyama M, Takahashi T, Matsuura K, Yamane T, Kuji I, Hasebe T, Osaki A. Shimada H, et al. Among authors: ueda s. Jpn J Clin Oncol. 2015 Jul;45(7):642-9. doi: 10.1093/jjco/hyv055. Epub 2015 May 19. Jpn J Clin Oncol. 2015. PMID: 25989989 Clinical Trial.

6

Near-Infrared Diffuse Optical Imaging for Early Prediction of Breast Cancer Response to Neoadjuvant Chemotherapy: A Comparative Study Using 18F-FDG PET/CT.

Ueda S, Yoshizawa N, Shigekawa T, Takeuchi H, Ogura H, Osaki A, Saeki T, Ueda Y, Yamane T, Kuji I, Sakahara H. Ueda S, et al. Among authors: ueda y. J Nucl Med. 2016 Aug;57(8):1189-95. doi: 10.2967/jnumed.115.167320. Epub 2016 Mar 3. J Nucl Med. 2016. PMID: 26940765 Free article.

7

In vivo imaging of eribulin-induced reoxygenation in advanced breast cancer patients: a comparison to bevacizumab.

Ueda S, Saeki T, Takeuchi H, Shigekawa T, Yamane T, Kuji I, Osaki A. Ueda S, et al. Br J Cancer. 2016 May 24;114(11):1212-8. doi: 10.1038/bjc.2016.122. Epub 2016 May 3. Br J Cancer. 2016. PMID: 27140309 Free PMC article. Clinical Trial.

8

Bevacizumab Induces Acute Hypoxia and Cancer Progression in Patients with Refractory Breast Cancer: Multimodal Functional Imaging and Multiplex Cytokine Analysis.

Ueda S, Saeki T, Osaki A, Yamane T, Kuji I. Ueda S, et al. Clin Cancer Res. 2017 Oct 1;23(19):5769-5778. doi: 10.1158/1078-0432.CCR-17-0874. Epub 2017 Jul 5. Clin Cancer Res. 2017. PMID: 28679773

9

Early metabolic response to neoadjuvant letrozole, measured by FDG PET/CT, is correlated with a decrease in the Ki67 labeling index in patients with hormone receptor-positive primary breast cancer: a pilot study.

Ueda S, Tsuda H, Saeki T, Omata J, Osaki A, Shigekawa T, Ishida J, Tamura K, Abe Y, Moriya T, Yamamoto J. Ueda S, et al. Breast Cancer. 2011 Oct;18(4):299-308. doi: 10.1007/s12282-010-0212-y. Epub 2010 Jul 9. Breast Cancer. 2011. PMID: 20617404 Clinical Trial.

10

18F-fluorodeoxyglucose positron emission tomography optimizes neoadjuvant chemotherapy for primary breast cancer to achieve pathological complete response.

Ueda S, Saeki T, Shigekawa T, Omata J, Moriya T, Yamamoto J, Osaki A, Fujiuchi N, Misumi M, Takeuchi H, Sakurai T, Tsuda H, Tamura K, Ishida J, Abe Y, Imabayashi E, Kuji I, Matsuda H. Ueda S, et al. Int J Clin Oncol. 2012 Jun;17(3):276-82. doi: 10.1007/s10147-011-0287-2. Epub 2011 Aug 10. Int J Clin Oncol. 2012. PMID: 21830087

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,093 results

Search Page